retatrutide efeitos colaterais A ciência está avançando rapidamente! 🧪 Nos próximos anos, medicamentos como Retatrutide, Survodutide, CagriSema e Orforglipron prometem revolucionar o tratamento da obesidade, com ainda mais eficácia e menos colaterais. ⚠️ Ainda Retatrutida: desistências por “emagrecer demais”?

It is important to note that not every GLP-1 medication is a weekly injection

Does the weight loss from retatrutide affect sperm quality

Retatrutide appears to cause even greater weight loss than tirzepatide, which has skyrocketed in demand in the U.S

This elevated GLP-1 medications from weight loss drugs to cardiovascular disease prevention tools in the eyes of major cardiology societies

The TRIUMPH-4 trial showed that retatrutide at 12mg reduced: Systolic blood pressure: 14.0 mmHg reduction Non-HDL cholesterol: clinically meaningful improvement High-sensitivity C-reactive protein: significant reduction (a marker of systemic inflammation) Triglycerides: substantial decrease Tirzepatide produces similar cardiovascular improvements, with well-documented reductions in blood pressure, triglycerides, and inflammatory markers across the SURMOUNT and SURPASS programs

The study, published Monday in the journal Nature Medicine, is one of the first big-picture looks at the benefits and risks of these new drugs, which rapidly made an impact on health care, insurance coverage, the grocery industry, and even the economy of an entire country (Denmark, where Novo Nordisk, the maker of Ozempic and Wegovy is based.) These drugs have also been given partial credit for a recent dip in obesity rates in the US, which dropped in 2023 for the first time in over a decade